MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-29-2025
Agilent Technologies Operating Cash Flow 2011-2025 | A
Annual Operating Cash Flow Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.48 B | 921 M | 1.02 B | 1.09 B | 889 M | 793 M | 512 M | 731 M | 1.15 B | 1.23 B | 1.26 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 B | 512 M | 1.01 B |
Quarterly Operating Cash Flow Agilent Technologies
| 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 431 M | - | - | 485 M | - | 255 M | - | - | - | 238 M | - | 710 M | - | -59 M | 544 M | 254 M | - | 213 M | 707 M | 465 M | - | 215 M | 715 M | 518 M | - | 116 M | 601 M | 373 M | - | 111 M | 559 M | 365 M | - | -20 M | 271 M | 163 M | - | 194 M | 547 M | 519 M | - | 245 M | 775 M | 560 M | - | 150 M | 743 M | 503 M | - | 120 M | 750 M | 498 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 775 M | -59 M | 395 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 18.71 | -3.41 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.72 | -2.15 % | $ 223 M |  China |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 0.23 | -1.28 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.08 | -0.8 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 230.45 | 0.06 % | $ 168 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.5 | -1.28 % | $ 1.91 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.65 | 6.03 % | $ 302 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.57 | - | $ 18.8 B | USA |
 |
DexCom
DXCM
|
748 M | $ 67.66 | 0.13 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.45 | -1.01 % | $ 800 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 19.01 | -2.41 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 101.35 | -0.88 % | $ 4 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.17 | -0.83 % | $ 101 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 226.47 | -0.2 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
-240 M | $ 101.35 | -1.59 % | $ 12.4 B | USA |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.32 | -2.41 % | $ 573 M | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.95 | -2.6 % | $ 2.66 M | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 7.17 | 0.56 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 18.83 | 0.88 % | $ 462 M | USA |
 |
Illumina
ILMN
|
837 M | $ 133.18 | -1.32 % | $ 21.2 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 202.55 | -0.55 % | $ 10.4 B | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
RadNet
RDNT
|
233 M | $ 73.13 | -0.03 % | $ 5.34 B | USA |
 |
Soleno Therapeutics
SLNO
|
-69.1 M | $ 47.69 | 0.08 % | $ 1.92 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 174.88 | -0.6 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 6.65 | -2.57 % | $ 862 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 252.38 | -0.59 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 182.35 | -0.27 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 682.6 | -0.85 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 66.84 | 0.19 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 407.81 | -0.87 % | $ 29.9 B |  Schweiz |